Company Filing History:
Years Active: 2021-2025
Title: Innovations of Meghan Kerrisk Campbell
Introduction
Meghan Kerrisk Campbell is a prominent inventor based in San Francisco, CA. She has made significant contributions to the field of medical research, particularly in the area of aging-associated diseases. With a total of four patents to her name, her work focuses on innovative treatments that aim to improve the quality of life for individuals facing age-related health challenges.
Latest Patents
One of Meghan's latest patents is titled "Benzodioxane modulators of leukotriene A4 hydrolase (LTA4H) for prevention and treatment of aging-associated diseases." This invention pertains to the prevention and treatment of aging-associated diseases. It relates to the use of benzodioxane inhibitors of leukotriene production through modulation of leukotriene A4 hydrolase (LTA4H) to treat and/or prevent conditions associated with aging, such as cognitive disorders, motor disorders, and neuroinflammation. Another significant patent is "Treatment of aging-associated disease with modulators of leukotriene A4 hydrolase." This patent describes methods and compositions for treating and/or preventing aging-related conditions, utilizing inhibitors or antagonists of leukotriene A4 hydrolase (LTA4H) with efficacy in treating and/or preventing aging-related conditions, including neurocognitive disorders.
Career Highlights
Meghan currently works at Alkahest, Inc., where she continues to develop her innovative ideas and research. Her work at Alkahest has positioned her as a key player in the field of aging research, contributing to advancements that could potentially transform treatment options for age-related diseases.
Collaborations
Some of Meghan's notable coworkers include Eva Czirr and Balazs Szoke. Their collaborative efforts contribute to the innovative environment at Alkahest, fostering advancements in research and development.
Conclusion
Meghan Kerrisk Campbell's contributions to the field of aging-associated diseases through her patents and work at Alkahest, Inc. highlight her commitment to improving health outcomes for the aging population. Her innovative approaches and collaborations are paving the way for future advancements in medical research.